AMDL Inc., a Tustin developer of diagnostic tests for cancer and other diseases, said Monday its shares have been relisted on the over-the-counter market under the symbol AMDD. The shares were delisted Aug. 3 until the company filed required documents with the Securities and Exchange Commission. The stock closed Monday at $5, up 38 cents a share, in trading of 400 shares. The shares closed at $2.50 on Aug. 3.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.